Shengxuan Wang
Papers
1
Total Citations
8
H-Index
1
About
Shengxuan Wang is a surgeon-scientist advancing the field of bariatric surgery through rigorous comparative effectiveness research. His work focuses on evaluating robotic and laparoscopic approaches to Roux-en-Y gastric bypass, with a particular emphasis on postoperative outcomes that matter most to patients—pain management and opioid requirements. In his landmark 2022 study, Wang conducted a critical evaluation of these two surgical modalities, providing evidence that helps guide clinical decision-making in an era of increasing robotic adoption. This work, which has already garnered 8 citations, addresses the pressing need for data-driven comparisons between established laparoscopic techniques and emerging robotic platforms. By quantifying differences in postoperative pain and opioid use, Wang’s research directly impacts patient recovery experiences and contributes to the broader effort to reduce opioid dependence after surgery. His findings offer surgeons and patients alike a clearer understanding of the trade-offs involved in choosing between these approaches. Wang’s contributions are particularly timely as the field seeks to balance technological innovation with evidence-based practice, making his work essential reading for clinicians and researchers dedicated to optimizing bariatric surgical outcomes.
Research Focus
Key Achievements
Top Papers
- 1